For example, overexpression of Transforming growth factor-alpha (TGF-α), one of the main ligands of the EGFR, has been observed in various of malignant tumors such as kidney cancer, pancreatic cancer, colon cancer and breast cancer [22–25]. This evidence concerns the gene TGFA and pancreatic neoplasm.